ALFA Finder| Metric | Q3 FY26 | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Total income | 1.0 | 0.0 | 0.0 |
| Net profit | -0.2 | -0.1 | -0.1 |
| Operating margin | -20.0% | 0.0% | 0.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
BSE results filing, NSE: FRASER. Figures extracted from the filing.
Fraser & Company Ltd: key numbers
- Share price
- ₹9.38
- Market cap
- ₹7.62 Cr
- Revenue (annual)
- ₹1.36 Cr
- Net profit (annual)
- ₹-0.61 Cr
- P/E (TTM)
- -11.1×Sector 46.1×
- Promoter holding
- 3.12%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fraser & Company Ltd
All →Fraser & Company Q2 FY27 Results: Net Profit ₹0 Cr
Fraser & Company Ltd reported revenue from operations of ₹0.2 Cr and net profit of ₹0 Cr for Q2 FY27.
- Key figure
- Net profit ₹0 Cr
Fraser & Company Management Change
Fraser and Company's executive director Yogeeta Shivhare resigned effective 6 November 2026. She cited family and personal reasons, with no other material reasons disclosed.
Fraser & Company Board Meeting Date
Fraser and Company has scheduled a board meeting on November 13, 2026 to approve unaudited standalone results for Q2 FY27. The agenda also notes a director's resignation and other routine items.
Fraser & Company Other Announcement
Fraser and Company Limited has submitted a disclosure confirming that the Regulation 32 statement of deviation or variation is not applicable for the quarter ended September 2026.
Fraser & Company Management Change
Fraser and Company redesignated Ms. Rekha Rani Naraniwal from Additional Non-Executive Independent Director to Non-Executive Independent Director effective 17-Sept-2026. No transaction or monetary value is involved.
Fraser & Company Annual General Meeting
Fraser and Company Limited held its 108th Annual General Meeting on September 17, 2026. The meeting covered financial adoption, director appointments, and object clause alteration.